Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*).
- DOI
- 10.1016/j.scr.2018.06.009
- Published
- 2018 Jul
- Container
- Stem cell research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.scr.2018.06.009,
title = {Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*).},
author = {Alari V and Russo S and Rovina D and Gowran A and Garzo M and Crippa M and Mazzanti L and Scalera C and Prosperi E and Giardino D and Gervasini C and Finelli P and Pompilio G and Larizza L},
year = {2018},
journal = {Stem cell research},
doi = {10.1016/j.scr.2018.06.009},
url = {https://doi.org/10.1016/j.scr.2018.06.009}
}RIS
TY - JOUR TI - Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*). AU - Alari V AU - Russo S AU - Rovina D AU - Gowran A AU - Garzo M AU - Crippa M AU - Mazzanti L AU - Scalera C AU - Prosperi E AU - Giardino D AU - Gervasini C AU - Finelli P AU - Pompilio G AU - Larizza L PY - 2018 JO - Stem cell research DO - 10.1016/j.scr.2018.06.009 UR - https://doi.org/10.1016/j.scr.2018.06.009 ER -
APA
V, A., S, R., D, R., A, G., M, G., M, C., L, M., C, S., E, P., D, G., C, G., P, F., G, P., & L, L. (2018). Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*).. Stem cell research. https://doi.org/10.1016/j.scr.2018.06.009
Source records
- pubmed · retrieved 2026-09-25T13:05:24.694Z